Recent Quotes (30 days)

You have no recent quotes
chg | %

ImmunoVaccine Inc.  

(Public, CVE:IMV)   Watch this stock  
Find more results for IMV
Delayed:   3:59PM EST
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.35 - 1.50
Open     -
Vol / Avg. 0.00/147,516.00
Mkt cap 67.59M
P/E     -
Div/yield     -
EPS -0.07
Shares 90.02M
Beta 1.17
Inst. own     -
Nov 12, 2015
Q3 2015 Immunovaccine Inc Earnings Release (Estimated) Add to calendar
Aug 12, 2015
Q2 2015 Immunovaccine Inc Earnings Release

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -104.63% -74.87%
Return on average equity -199.35% -126.25%
Employees 23 -
CDP Score - -


1344 Summer Street, Suite 412
+1-902-4921819 (Phone)
+1-902-4920888 (Fax)

Website links


Immunovaccine Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops products that activate the immune system to treat cancer and infectious diseases. The Company has a product platform that is used to create highly immunogenic vaccines. The Company develops cancer immunotherapies and infectious disease vaccines based on its DepoVax platform, a formulation that provides controlled and prolonged exposure of antigens and adjuvant to the immune system. The Company has advanced two T cell activation therapies for cancer through Phase I human clinical trials. One of its cancer vaccine candidates is being tested in a Phase II trial in lymphoma. The Company is also advancing an infectious disease pipeline, including vaccines for respiratory syncytial virus (RSV) and anthrax.

Officers and directors

Marc Mansour Ph.D. Chief Executive Officer, Director
Age: 39
Kimberly Stephens Chief Financial Officer, Corporate Secretary
Frederic Ors Chief Business Officer
Age: 41
Albert James Scardino Non-Executive Chairman
Age: 65
Wade K. Dawe Independent Director
James W. Hall C.P.A Independent Director
Age: 65
Wayne F. Pisano Independent Director
Alfred A. Smithers Independent Director